MLICM
STML
Metropolitan Life Insurance Company (MetLife)’s Stemline Therapeutics, Inc. STML Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-13,714
| Closed | -$66.4K | – | 2632 |
|
|
2020
Q1 | $66.4K | Buy |
13,714
+1,729
| +14% | +$8.37K | ﹤0.01% | 2276 |
|
|
2019
Q4 | $127K | Sell |
11,985
-1,373
| -10% | -$14.6K | ﹤0.01% | 2183 |
|
|
2019
Q3 | $139K | Hold |
13,358
| – | – | ﹤0.01% | 2121 |
|
|
2019
Q2 | $205K | Hold |
13,358
| – | – | ﹤0.01% | 1878 |
|
|
2019
Q1 | $172K | Buy |
13,358
+4,835
| +57% | +$62.1K | ﹤0.01% | 2004 |
|
|
2018
Q4 | $81K | Hold |
8,523
| – | – | ﹤0.01% | 2403 |
|
|
2018
Q3 | $141K | Hold |
8,523
| – | – | ﹤0.01% | 2242 |
|
|
2018
Q2 | $137K | Buy |
8,523
+434
| +5% | +$6.97K | ﹤0.01% | 2159 |
|
|
2018
Q1 | $124K | Hold |
8,089
| – | – | ﹤0.01% | 2179 |
|
|
2017
Q4 | $126K | Sell |
8,089
-7,674
| -49% | -$120K | ﹤0.01% | 2182 |
|
|
2017
Q3 | $175K | Buy |
+15,763
| New | +$175K | ﹤0.01% | 2335 |
|
|
2015
Q2 | – | Sell |
-12,765
| Closed | -$185K | – | 2717 |
|
|
2015
Q1 | $185K | Buy |
+12,765
| New | +$185K | ﹤0.01% | 2099 |
|
|
2014
Q2 | – | Sell |
-7,976
| Closed | -$162K | – | 2827 |
|
|
2014
Q1 | $162K | Hold |
7,976
| – | – | ﹤0.01% | 2587 |
|
|
2013
Q4 | $156K | Hold |
7,976
| – | – | ﹤0.01% | 2618 |
|
|
2013
Q3 | $361K | Hold |
7,976
| – | – | ﹤0.01% | 1979 |
|
|
2013
Q2 | $190K | Buy |
+7,976
| New | +$190K | ﹤0.01% | 2386 |
|